BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15658437)

  • 21. Correlation of specific platelet activation markers with carotid arterial wall thickness.
    Ghaddar HB; Cortes J; Salomaa V; Kark JD; Davis CE; Folsom AR; Heiss G; Stinson V; Wu KK
    Thromb Haemost; 1995 Sep; 74(3):943-8. PubMed ID: 8571326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study on the platelet factor and beta-thromboglobulin in the patients with ischemic heart disease.
    Kim MH; Huo SH; Kim KS; Kim MS; Song JS
    Korean J Intern Med; 1986 Jan; 1(1):1-6. PubMed ID: 15759368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical significance of platelet factor 4 analysis in blood coagulo-fibrinolytic tests].
    Kimura A; Kuramoto A
    Nihon Rinsho; 1989 Dec; 48 Suppl():927-9. PubMed ID: 2622031
    [No Abstract]   [Full Text] [Related]  

  • 24. Laboratory application of radioimmunoassay in the quantitation of molecular markers of hemostatic activation.
    Walenga JM; Fareed J; Hoppensteadt D
    Semin Thromb Hemost; 1984 Oct; 10(4):294-305. PubMed ID: 6240117
    [No Abstract]   [Full Text] [Related]  

  • 25. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
    Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
    Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet markers of thromboembolic disease.
    Wohl H
    West J Med; 1981 Jul; 135(1):19-24. PubMed ID: 6167074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical applications of beta-thromboglobulin and platelet factor 4 radioimmune assays (author's transl)].
    Lokiec F; Najean Y
    Nouv Presse Med; 1980 Oct; 9(38):2833-4, 2837-8. PubMed ID: 6160454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A reliable plasma marker of platelet activation: does it exist?
    Gurney D; Lip GY; Blann AD
    Am J Hematol; 2002 Jun; 70(2):139-44. PubMed ID: 12111787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated fibrin-related markers in patients with malignant diseases suspected of having thrombotic disorders.
    Nomura H; Wada H; Mizuno T; Yamashita Y; Saito K; Kitano S; Katayama N; Yamada N; Sugiyama T; Sudo A; Usui M; Isaji S; Nobori T
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):266-72. PubMed ID: 19648145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standardization of beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4): a collaborative study to establish international standards for beta-TG and PF4.
    Kerry PJ; Curtis AD
    Thromb Haemost; 1985 Feb; 53(1):51-5. PubMed ID: 2581331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. beta-Thromboglobulin.
    Kaplan KL
    Prog Hemost Thromb; 1980; 5():153-78. PubMed ID: 6158743
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of platelet damage in two different centrifugal pumps based on measurements of alpha-granule packing proteins.
    Mohara J; Kawahito K; Misawa Y; Fuse K
    Artif Organs; 1998 May; 22(5):371-4. PubMed ID: 9609343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fibrinogen (factor I) and dys (functional) -fibrinogen].
    Hiura H
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():597-9. PubMed ID: 15658399
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased platelet destruction.
    Neame PB; Hirsh J
    Semin Thromb Hemost; 1982 Apr; 8(2):75-82. PubMed ID: 6210959
    [No Abstract]   [Full Text] [Related]  

  • 35. Platelet and coagulation function in patients with abnormal cardiac valves treated with sulphinpyrazone.
    Ludlam CA; Allan N; Blandford RB; Dowdle R; Bentley NJ; Bloom AL
    Thromb Haemost; 1981 Dec; 46(4):743-6. PubMed ID: 6460338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Protein C inhibitor (PCI)].
    Saito H
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():671-3. PubMed ID: 15658420
    [No Abstract]   [Full Text] [Related]  

  • 37. Does the beta-TG/PF4 ratio have any value?
    Arocha-PiƱango CL; Ojeda A
    Thromb Haemost; 1983 Apr; 49(2):147. PubMed ID: 6191402
    [No Abstract]   [Full Text] [Related]  

  • 38. Elevated plasma levels of beta-thromboglobulin and platelet factor 4 in patients with rheumatic disorders and cutaneous vasculitis.
    Yamamoto T; Chikugo T; Tanaka Y
    Clin Rheumatol; 2002 Nov; 21(6):501-4. PubMed ID: 12447635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of pressure excursions on human platelets. In vitro studies on betathromboglobulin (beta-TG) and platelet factor 4 (PF4) release and on platelet sensitivity to ADP-aggregation.
    Torsellini A; Becucci A; Citi S; Cozzolino F; Guidi G; Lombardi V; Vercelli D; Veloci M
    Haematologica; 1982; 67(6):860-6. PubMed ID: 6186580
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
    Seibold JR; Harris JN
    J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.